Myriad Genetics, Inc.
Status: Publicly traded
Direct answer
Myriad Genetics, Inc. is publicly traded on NASDAQ under the ticker MYGN.
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic...
Can you invest in Myriad Genetics, Inc.?
Yes. Myriad Genetics, Inc. trades publicly on NASDAQ as MYGN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Myriad Genetics, Inc.
Detailed equity research is provided by MarketSnap.